Prepare the mind: can coaching in goal-directed behavior increase the success of cognitive rehabilitation in people with multiple sclerosis? - a study protocol of a multicenter randomized controlled trial

Up to 70% of people with multiple sclerosis (PwMS) experience cognitive impairment, particularly in information processing speed and memory. Although cognitive rehabilitation (CR) can improve cognitive function, treatment response varies substantially, limiting routine clinical implementation. Higher trait conscientiousness (i.e., the tendency to be diligent, organized, and goal-oriented) has been associated with better cognitive outcomes, slower disease progression, and reduced brain atrophy in PwMS. Conscientiousness coaching (C-Coach), a blended intervention combing tele-coaching and smartphone support, has been shown to enhance conscientiousness and goal-directed behavior. It may therefore optimize responsiveness to CR. To investigate whether PwMS receiving C-Coach prior to CR show greater improvement in processing speed and self-reported everyday cognitive functioning, compared with PwMS receiving a sham intervention before CR. In this international, multicenter, randomized double-blinded, parallel-group trial will include 126 PwMS (aged 18–65 years) allocated 1:1 to C-Coach or an active sham intervention for 12-weeks followed by 6-weeks of home-based digital CR (Brain HQ). C-Coach includes one initial coaching session and two booster sessions focused on identifying core values and associated goals, supported by weekly check-ins and the smartphone app. The sham intervention is an active control with the same coaching interactions but focused on reflecting on daily experiences. Participants will be recruited from the Netherlands, US, New Zealand, and Switzerland. Main outcomes at baseline, 12-weeks (post-C-Coach), and 18-weeks (post-BrainHQ) are processing speed measured (Symbol Digit Modalities Test) and self-reported cognition (Multiple Sclerosis Instrumental Activities of Daily Living Questionnaire), and secondary outcomes are psychological (meaning of life, fatigue, depression, anxiety, health-related quality of life), neurobiological (cognitive performance and functional brain networks), and social support. Dutch participants additionally undergo MRI scanning. We hypothesize that strengthening conscientiousness before CR will enhance treatment responsiveness, resulting in superior cognitive and psychosocial outcomes. By targeting behavioral readiness for rehabilitation, this study advances a scalable and theory-driven model for personalized neurorehabilitation in MS. Registered prospectively on ClinicalTrials.gov (NCT07225868) on 06 November 2025.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-11-10
DOI
https://doi.org/10.1186/s12883-026-05573-2
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prepare the mind: can coaching in goal-directed behavior increase the success of cognitive rehabilitation in people with multiple sclerosis? - a study protocol of a multicenter randomized controlled trial

Marit F. L. Ruitenberg, Corina Schuster‐Amft, Celeste A Santivasci, Véronique De Gucht et al.
BMC Neurology
Multiple Sclerosis Research Studies
article

Prepare the mind: can coaching in goal-directed behavior increase the success of cognitive rehabilitation in people with multiple sclerosis? - a study protocol of a multicenter randomized controlled trial

Marit F. L. Ruitenberg, Corina Schuster‐Amft, Celeste A Santivasci, Véronique De Gucht, Ralph H. B. Benedict, Priska Zuber, Hanneke E. Hulst, Tom A. Fuchs, Benson S. Chen, Charlotte C. Rouzée
article en

Abstract

Up to 70% of people with multiple sclerosis (PwMS) experience cognitive impairment, particularly in information processing speed and memory. Although cognitive rehabilitation (CR) can improve cognitive function, treatment response varies substantially, limiting routine clinical implementation. Higher trait conscientiousness (i.e., the tendency to be diligent, organized, and goal-oriented) has been associated with better cognitive outcomes, slower disease progression, and reduced brain atrophy in PwMS. Conscientiousness coaching (C-Coach), a blended intervention combing tele-coaching and smartphone support, has been shown to enhance conscientiousness and goal-directed behavior. It may therefore optimize responsiveness to CR. To investigate whether PwMS receiving C-Coach prior to CR show greater improvement in processing speed and self-reported everyday cognitive functioning, compared with PwMS receiving a sham intervention before CR. In this international, multicenter, randomized double-blinded, parallel-group trial will include 126 PwMS (aged 18–65 years) allocated 1:1 to C-Coach or an active sham intervention for 12-weeks followed by 6-weeks of home-based digital CR (Brain HQ). C-Coach includes one initial coaching session and two booster sessions focused on identifying core values and associated goals, supported by weekly check-ins and the smartphone app. The sham intervention is an active control with the same coaching interactions but focused on reflecting on daily experiences. Participants will be recruited from the Netherlands, US, New Zealand, and Switzerland. Main outcomes at baseline, 12-weeks (post-C-Coach), and 18-weeks (post-BrainHQ) are processing speed measured (Symbol Digit Modalities Test) and self-reported cognition (Multiple Sclerosis Instrumental Activities of Daily Living Questionnaire), and secondary outcomes are psychological (meaning of life, fatigue, depression, anxiety, health-related quality of life), neurobiological (cognitive performance and functional brain networks), and social support. Dutch participants additionally undergo MRI scanning. We hypothesize that strengthening conscientiousness before CR will enhance treatment responsiveness, resulting in superior cognitive and psychosocial outcomes. By targeting behavioral readiness for rehabilitation, this study advances a scalable and theory-driven model for personalized neurorehabilitation in MS. Registered prospectively on ClinicalTrials.gov (NCT07225868) on 06 November 2025.

BMC Neurology
Leiden University (NL), Bern University of Applied Sciences (CH), Pennsylvania State University (US), University of Auckland (NZ), University of Basel (CH), Auckland City Hospital (NZ), Amsterdam University Medical Centers (NL), Reha Rheinfelden (CH), University at Buffalo, State University of New York (US)
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon